Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Perseon Corporation PRSN NASDAQ

NASDAQ • Healthcare • Medical - Devices • US • USD

SharesGrow Score
36/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Perseon Corporation (PRSN) is a Medical - Devices company in the Healthcare sector, currently trading at $0.07. It has a SharesGrow Score of 34/100, indicating a weak investment profile with 1 out of 7 criteria passed.

Financials: revenue is $2M, -21.1%/yr average growth. Net income is $8M (loss), growing at +54.5%/yr. Net profit margin is -384.4% (negative). Gross margin is 26.8% (-18.8 pp trend).

Balance sheet: total debt is $0 against $14M equity (Debt-to-Equity (D/E) ratio 0, conservative). Current ratio is 18.79 (strong liquidity). Debt-to-assets is 0%. Total assets: $15M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 100/100 (Pass), Moat 14/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

PRSN SharesGrow Score Overview

46/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 100/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 14/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — PRSN

—
VALUE N/A
N/A
No analyst coverage available for this stock.
~
GROWTH Partial
58/100
PRSN: -21.1%/yr revenue is, +54.5%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✓
HEALTH Pass
100/100
Balance sheet PRSN: Debt-to-Equity (D/E) ratio 0 (conservative), Current ratio is 18.79 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
14/100
PRSN: Gross margin is 26.8% (-18.8 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 14/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
PRSN: Net profit margin is -384.4%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range3.32-0.0516
Volume426.8K
Avg Volume (30D)190.3K
Beta (1Y)10.84
Share Statistics
EPS (TTM)-0.27
Shares Outstanding$29.72M
IPO Date2005-06-23
Financial Highlights & Ratios
Revenue (TTM)$2.07M
Gross Profit$554.56K
EBITDA$-7.81M
Net Income$-7.96M
Operating Income$-8.01M
Total Cash$11.14M
Net Debt$-11.1M
Total Assets$15.37M
Price / Earnings (P/E)-0.2
Analyst Forecast
Company Info
CountryUS
ExchangeNASDAQ
CurrencyUSD
ISINUS7152702038

Price Chart

Track all markets on TradingView
PRSN
Perseon Corporation ↗  ·  NASDAQ
Healthcare • Medical - Devices

People Also View

LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
 RHHBF
RHHBF
Roche Holding AG
$418.50
+1.82%
 RHHBY
RHHBY
Roche Holding AG
$51.02
+0.65%
 AZN
AZN
AstraZeneca PLC
$204.38
+1.06%
 NVSEF
NVSEF
Novartis AG
$156.48
+0.00%
 MRK
MRK
Merck & Co., Inc.
$119.96
-0.16%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message